Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 11, keine Gesamtzahl für „enzymes“
Suchtreffer
Begriffe & Kennungen
Hulio · 4.8 · Rare Intestinal perforation1) Hepato-biliary disorders* Very common Elevated liver enzymes
Eintrag öffnenHumira · 4.8 · Hepato-biliary disorders* Very Common Elevated liver enzymes
Eintrag öffnenHumira · 4.8 · Hepato-biliary disorders* Very Common Elevated liver enzymes
Eintrag öffnenHumira · 4.8 · Hepato-biliary disorders* Very Common Elevated liver enzymes
Eintrag öffnenHycamtin · 4.5 · Topotecan does not inhibit human P450 enzymes (see section 5.2). In a population study using the intravenous r
Eintrag öffnenHycamtin · 4.5 · Topotecan does not inhibit human P450 enzymes (see section 5.2). In a population study using the intravenous r
Eintrag öffnenHyrimoz · 4.8 · 20 System Organ Class Frequency Adverse Reaction Hepato-biliary Very common Elevated liver enzymes disorders*
Eintrag öffnenHyrimoz · 4.8 · Hepato-biliary Very common Elevated liver enzymes disorders* Uncommon Cholecystitis and cholelithiasis, hepati
Eintrag öffnenIdacio · 4.8 · Hepatobiliary disorders* Very Common Elevated liver enzymes
Eintrag öffnenIlaris · 4.5 · The expression of hepatic CYP450 enzymes may be suppressed by the cytokines that stimulate chronic inflammatio
Eintrag öffnenInovelon · 4.5 · 6 Cytochrome P450 enzymes Rufinamide is metabolised by hydrolysis, and is not metabolised to any notable degre
Eintrag öffnenInovelon · 4.5 · Cytochrome P450 enzymes Rufinamide is metabolised by hydrolysis, and is not metabolised to any notable degree
Eintrag öffnenInrebic · 4.5 · Effects on enzymes: CYP3A4, CYP2C19 or CYP2D6 substrates Concomitant administration of fedratinib with the CYP
Eintrag öffnenInvokana · 4.5 · If a combined inducer of these UGT enzymes and transport proteins must be co-administered with canagliflozin,
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIsentress · 4.5 · In vitro studies indicate that raltegravir is not a substrate of cytochrome P450 (CYP) enzymes, does not inhib
Eintrag öffnenIsentress · 4.5 · Inducers of drug metabolizing enzymes The impact of medicinal products that are strong inducers of UGT1A1 such
Eintrag öffnenIsoenzyme
Eintrag öffnen